Clinical Trials Sponsored by Yvonne Efebera

Total 16 results

Yvonne Efebera
Bristol-Myers Squibb; National Cancer Institute (NCI); American Cancer Society...

Terminated

Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Yvonne Romero
Bausch Health Americas, Inc.

Completed

Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

Erosive Esophagitis

United States
Yvonne Colgrove, PT, PhD

Completed

The Effect of Yoga in Chronic Low Back Pain

Low Back Pain

United States
Embera NeuroTherapeutics, Inc.

Completed

A Placebo-Controlled Study of a Combination of Metyrapone and Oxazepam in Cocaine Addiction

Cocaine Dependence | Cocaine Addiction

United States
Philipps University Marburg Medical Center
Gaia AG; Prof. Dr. Yvonne Nestoriuc

Terminated

Psychological Online-training to Optimize Adherence in Patients With Type-II Diabetes (ONSIDE)

Diabetes Mellitus Type 2

Germany
Dionne Peacher

Withdrawn

Individualized vs Low PEEP in One Lung Ventilation

Lung Diseases | Obesity | One-Lung Ventilation

United States
Charlotte Sonne
Psychiatric Center Ballerup

Completed

The Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With Psychotherapy (PTF3)

Depression | Post Traumatic Stress Disorder

Denmark
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001)

Tobacco Use Disorder | Cocaine Use Disorder

United States
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study to Evaluate EMB 001 in Subjects With Cocaine Use Disorder

Cocaine Use Disorder

United States
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations

Cocaine Use Disorder

United States
Embera NeuroTherapeutics, Inc.
National Institute on Drug Abuse (NIDA)

Completed

A Study of Metyrapone and Oxazepam Combination Product (EMB-001) and Cocaine

Cocaine Use Disorder

United States
Rose Research Center, LLC
Foundation for a Smoke-Free World; Embera NeuroTherapeutics, Inc.

Recruiting

Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment

Smoking Cessation | Tobacco Use Disorder

United States
Embera NeuroTherapeutics, Inc.
Rose Research Center, LLC; Segal Trials; Foundation for a Smoke Free World INC

Terminated

Study of EMB-001 as a Potential Smoking Cessation Treatment

Tobacco Use Disorder

United States
Assistance Publique - Hôpitaux de Paris
Saint Antoine Hospital (Pr Yvon Camus)

Completed

Is Access to Liver Transplantation Similar in Alcoholic or Not Patients? (TRANSALC)

Inpatient With End Stage Liver Disease

France
Copenhagen Trial Unit, Center for Clinical Intervention...
The Info Trial Group; Charlotte Behnke; Pia Caspersen; Dorte Fischer; Rolf I. Hansen and other collaborators

Completed

Outpatients' Knowledge About and Attitude Toward Randomised Clinical Trials (INFO-I)

Ambulatory Patients in the Dep. of Medical Gastroenterology | Ambulatory Patients in the Dep. of Gynecology | Ambulatory Patients in the Dep. of Orthopedic Surgery | Ambulatory Patients in the Dep. of Urology

Denmark
Hospital Donación Francisco Santojanni
Matías Bertozzi; Marco Bezzi; Silvina Borello; Daniela Castro; Victoria Di Giorgio; Mariana Aguirre and other collaborators

Terminated

Comparison of Two Extubation Techniques in Critically Ill Adult Patients (ExtubAR)

Mechanical Ventilation Complication | Weaning Failure

Argentina

Clinical Trials Sponsored by Yvonne Efebera

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations